SG3 Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,000
Closed -$182K 1329
2021
Q1
$182K Sell
1,000
-6,000
-86% -$1.39M ﹤0.01% 983
2020
Q4
$1.4M Buy
7,000
+6,000
+600% +$1.22M 0.03% 478
2020
Q3
$219K Buy
+1,000
New +$212K 0.01% 715

Other funds holding TDOC

SG3 Management's TDOC Position: Q2 2022 in Review

SG3 Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,000 shares — an estimated $289K sold.

SG3 Management first reported a position in TDOC in Q3 2020 and held it in 5 quarters. The position peaked at $1.08M in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • SG3 Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 4,000 Teladoc Health shares in Q2 2022, an estimated $289K.
  • SG3 Management first reported a position in Teladoc Health in Q3 2020 and held it in 5 quarters.
  • SG3 Management's Teladoc Health position peaked at $1.08M in Q3 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.